KPH Healthcare Services, Inc. v. Takeda Pharmaceutical Company Ltd. et al

  1. January 23, 2023

    Court Consolidates Takeda Antitrust Suits Over IBS Drug

    A Massachusetts federal judge on Monday consolidated a pair of proposed class actions alleging that Takeda Pharmaceutical broke antitrust law by cutting a pay-for-delay deal to keep a generic version of its anti-constipation drug Amitiza off the market for over six years.

  2. August 03, 2021

    Takeda Kept Generic Drug Off Shelves For 6 Years, Suit Says

    Takeda Pharmaceutical Co. Ltd. was hit with a proposed class action Tuesday in Massachusetts federal court by a drug company who claims the pharmaceutical giant paid a competitor to keep a generic anti-constipation drug off the market for six years to preserve Takeda's monopoly.